The peptide industry is a rapidly growing multi-billion-dollar sector, with many companies marketing peptides exclusively for laboratory and research purposes while expressly prohibiting human consumption. FDA regulatory concerns and allegations of patent infringement involving certain peptide compounds, along with actions taken by private compliance organizations such as LegitScript, can result in website restrictions, advertising suspensions, payment processing disruptions, and other operational challenges before any court or government agency has made a final determination regarding the company's legal compliance. Many peptide businesses encounter domain disputes under ICANN's UDRP process, in which businesses seek to obtain valuable domain names through administrative proceedings rather than traditional litigation.  These factors can significantly disrupt business operations. Davis Law & Consulting assists businesses with UDRP proceedings, domain disputes, payment processor fund holds, reserve disputes, banking issues, and online business litigation.